Article Sidebar

Portada Volumen 27, número 2, abril-junio 2024
Submitted
April 15, 2024
Published
June 30, 2024
Download
pdf (Español (España)) html (Español (España)) xml (Español (España))
Statistic
Read Counter : 319 Download : 45

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Main Article Content

Abstract

Introduction: Adherence to immunotherapy decreases rejection and graft loss, so it is necessary to identify clinical variables related to adherence in adult renal transplant recipients to optimise renal graft survival.
Objetive: To assess the prevalence of adherence to immunotherapy and its relationship with clinical variables in young adult kidney transplant recipients in a tertiary hospital.
Material and Method: Descriptive cross-sectional observational study. A non-probabilistic convenience sample was taken from 45 adult kidney transplant recipients. Sociodemographic and clinical variables, anxiety, and depression were studied. The Basel Assessment of Adherence to Immunosuppressive Medications Scale was used to assess adherence.
Results: The mean age of the participants was 33.7±9.4 years. The majority were men (66.7%). The prevalence of non-adherence was 75.5%; an association was observed between adherence and the reason for hospital admission and anxiety. Non-adherent adults showed problems such as forgetting to take the immunosuppressant and delay of at least 2 hours in taking the medication.
Conclusions: The prevalence of non-adherence to immunotherapy was higher than reported in previous studies, so continued intervention is needed to improve adherence to immunosuppressive therapy recommendations.

Keywords

compliance and adherence to treatment anxiety depression transplant nursing

Article Details

License

Copyright (c) 2024 Rosa María Rodríguez Medina, Yosileb Sinai Aranda Hernández, María Beatriz Cruz Sánchez, Carlos Francisco Meza García

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Author copyright notice

© Authors grant the publisher the non-exclusive licence to publish the work and consent to its use and distribution under the Creative Commons Attribution - NonCommercial 4.0 International (CC BY-NC 4.0) licence. Read the licensing information and the legal text here. This must be expressly stated wherever necessary.

How to Cite
1.
Rodríguez Medina RM, Aranda Hernández YS, Cruz Sánchez MB, Meza García CF. Adherence to immunotherapy and its relationship with clinical variables in young adult kidney transplant recipients. Enferm Nefrol [Internet]. 2024 [cited 2025 Apr 30];27(2):[about 7 p.]. Available from: https://www.enfermerianefrologica.com/revista/article/view/4759
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Ali A, Al-Taee HA, Jasim MS. Adherence to Immunosuppressive Medication in Iraqi Kidney Transplant Recipients During the First Year of Transplant. A Single-Center Experience. Exp Clin Transplant. 2022;20(3):107-12. DOI: https://doi.org/10.6002/ect.MESOT2021.P44
  2. Nevins TE, Nickerson PW, Dew MA. Understanding Medication Nonadherence after Kidney Transplant. J Am Soc Nephrol. 2017;28(8):2290-301. DOI: https://doi.org/10.1681/ASN.2017020216
  3. Weng LC, Yang YC, Huang HL, Chiang YJ, Tsai YH. Factors that determine self-reported immunosuppressant adherence in kidney transplant recipients: a correlational study. J Adv Nurs. 2017;73(1):228-39. DOI: https://doi.org/10.1111/jan.13106
  4. Villeneuve C, Rousseau A, Rerolle JP, Couzi L, Kamar N, Essig M, et al. Adherence profiles in kidney transplant patients: Causes and consequences. Patient Educ Couns. 2020;103(1):189-98. DOI: https://doi.org/10.1016/j.pec.2019.08.002
  5. Doalto-Muñoz Y, Valle RC, Manrique MLC. Factores asociados a la resiliencia y adherencia terapéutica en pacientes con injerto renal funcionante. Enferm Nefrol. 2018;21(2):123-9. DOI: https://doi.org/10.4321/S2254-28842018000200003
  6. Argüeso-Gómez L, Rodrigo-Calabia E, Pelayo-Alonso R, de Cos-Cossío MÁ. Adherencia al tratamiento en pacientes con trasplante renal y su relación con los niveles plasmáticos de inmunosupresores. Enferm Nefrol. 2023;26(4):344-50. DOI: https://doi.org/10.37551/S2254-28842023033
  7. Belaiche S, Décaudin B, Dharancy S, Noel C, Odou P, Hazzan M. Factors relevant to medication non-adherence in kidney transplant: a systematic review. Int J Clin Pharm. 2017;39(3):582-93. DOI: https://doi.org/10.1007/s11096-017-0436-4
  8. Guillén Díaz-Barriga C, González-Celis Rangel AL. Propiedades psicométricas del Inventario de Ansiedad de Beck en adultos asmáticos mexicanos. Psicología y Salud. 2018;29(1):5-16. DOI: https://doi.org/10.25009/pys.v29i1.2563
  9. Brito DCS de, Machado EL, Reis IA, Cherchiglia LP de F do CML. Depression and anxiety among patients undergoing dialysis and kidney transplantation: A cross-sectional study. Sao Paulo Med J. 2019;137(2):137-47. DOI: https://doi.org/10.1590/1516-3180.2018.0272280119
  10. Sevinc M, Hasbal NB, Sakaci T, Basturk T, Ahbap E, Ortaboz M, et al. Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic. PLoS One. 2021;16(1):0244347. DOI: https://doi.org/10.1371/journal.pone.0244347
  11. Baloch MH AA. Prevalence of anxiety and depression in chronic kidney disease patients according to CKD stages. Isra Med J. 2017;9(5):280–3.
  12. Low JK, Manias E, Crawford K, Walker R, Mulley WR, Toussaint ND, et al. Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial. Sci Rep. 2019;9:7734. DOI: https://doi.org/10.1038/s41598-019-44002-y
  13. Krause AV, Bertram A, Nöhre M, Bauer-Hohmann M, Schiffer M, De Zwaan M. Use of an electronic medication monitoring device to estimate medication adherence in kidney transplant patients. Transl Behav Med. 2021;11(3):842–51. DOI: https://doi.org/10.1093/tbm/ibaa122
  14. Rodríguez-Medina RM, et al. https://doi.org/10.37551/S2254-28842024017 DOI: https://doi.org/10.37551/S2254-28842024017
  15. Secretaría de Gobernación de México. Reglamento de la Ley General de Salud en materia de investigación para la salud. Publicado en Diario Oficial de la Federación en 2014.
  16. Martínez-Mier G, Ávila-Pardo SF, Irigoyen-Castillo A, Rodríguez-Fernández A, Jiménez-López LA, Varela-Pérez V. Análisis de la supervivencia a 10 años de trasplante renal en el Hospital de Alta Especialidad de Veracruz. Rev Mex Traspl. 2016;5(3):113–9.
  17. Ayala-García MA, Díaz-Chávez E, Soel-Encalada JM, Orozco-Mosqueda A, Balandrán-Ortiz MH, Ceja-Guzmán SR, et al. Supervivencia de los pacientes receptores de trasplante renal. Gac Med Mex. 2020;156(1):34–9. DOI: https://doi.org/10.24875/GMM.19005434
  18. Taj SM, Baghaffar H, Alnajjar DK, Almashabi NK, Ismail S. Prevalence of non-adherence to immunosuppressive medications in kidney transplant recipients: Barriers and predictors. Ann Transplant. 2021;26:928356. DOI: https://doi.org/10.12659/AOT.928356
  19. Massey EK, Meys K, Kerner R, Weimar W, Roodnat J, Cransberg K. Young adult kidney transplant recipients: Nonadherent and happy. Transplantation. 2015;99(8):89-96. DOI: https://doi.org/10.1097/TP.0000000000000639
  20. Lalić J, Velicković-Radovanović R, Mitić B, Paunović G, Cvetković T. Immunosuppressive medication adherence in kidney transplant patients. Med Princ Pract. 2014;23(4):351-6. DOI: https://doi.org/10.1159/000362792
  21. Matsuda-Abedini M, Marks SD, Foster BJ. Transition of young adult kidney transplant recipients. Pediatr Nephrol. 2023;38(2):383-90. DOI: https://doi.org/10.1007/s00467-022-05582-6
  22. Van Zanten R, de Weerd A, Betjes M, Boer-Verschragen M, Massey EK. Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial. Transpl Int. 2021;34(9):1703-11. DOI: https://doi.org/10.1111/tri.13993
  23. Uyar B. The analysis of immunosuppressant therapy adherence, depression, anxiety, and stress in kidney transplant recipients in the post-transplantation period. Transpl Immunol. 202;75:101686. DOI: https://doi.org/10.1016/j.trim.2022.101686
  24. Rebafka A. Medication adherence after renal transplantation—a review of the literature. J Ren Care. 2016;42(4):239-56. DOI: https://doi.org/10.1111/jorc.12181
  25. Varnell CD, Rich KL, Modi AC, Hooper DK, Eckman MH. A cost-effectiveness analysis of adherence promotion strategies to improve rejection rates in adolescent kidney transplant recipients. Am J Kidney Dis. 2022;80(3):330-40. DOI: https://doi.org/10.1053/j.ajkd.2021.12.013
  26. Kim S, Ju MK, Son S, Jun S, Lee SY, Han CS. Development of video-based educational materials for kidney-transplant patients. PLoS One. 2020;15(8):0236750. DOI: https://doi.org/10.1371/journal.pone.0236750
  27. Pedreira-Robles G, Garcimartín P, Bach-Pascual A, Giró-Formatger D, Redondo-Pachón D, Morín-Fraile V. Creating the nursing care map in the evaluation of kidney transplant candidates: A scoping review and narrative synthesis. Nursing Open 2023;10:6668–89. DOI: https://doi.org/10.1002/nop2.1937

Similar Articles

<< < 37 38 39 

You may also start an advanced similarity search for this article.